Higher LINAC SRS dose rate was linked to longer pain control in trigeminal neuralgia
Treatment failure at one year was 14.4% at 2400 MU/min versus 42.7% at 800 MU/min, with similar facial numbness.
Treatment failure at one year was 14.4% at 2400 MU/min versus 42.7% at 800 MU/min, with similar facial numbness.
Distal targeting produced more overall pain relief, while proximal targeting yielded more complete pain freedom and medication discontinuation.